EA
IRWD icon

Emerald Acquisition’s Ironwood Pharmaceuticals IRWD Stock Holding History

Emerald Acquisition’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$471K Buy
35,390
+13,358
+61% +$156K ﹤0.01% 2462
2016
Q2 		$241K Buy
+22,032
New +$215K ﹤0.01% 2689

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Acquisition's IRWD Position: Q3 2016 in Review

Emerald Acquisition increased its Ironwood Pharmaceuticals (IRWD) stake by 61% in Q3 2016, buying an estimated $156K and bringing the position to 35,390 shares worth $471K. The position accounts for ﹤0.01% of the portfolio, ranked #2462.

Emerald Acquisition first reported a position in IRWD in Q2 2016 and has held it in 2 quarters since. 155 funds tracked by Wall St. Rank hold IRWD as of Q3 2016.

  • Emerald Acquisition held 35,390 shares of Ironwood Pharmaceuticals worth $471K as of Q3 2016.
  • Emerald Acquisition bought 13,358 Ironwood Pharmaceuticals shares in Q3 2016, an estimated $156K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2462 holding.
  • Emerald Acquisition first reported a position in Ironwood Pharmaceuticals in Q2 2016 and has held it in 2 quarters since.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.